Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bone Metastasis on the Survival of Gefitinib Effective Patients With Non-small Cell Lung Cancer

NCT03157310 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.

NCT NCT03157310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03157310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bone Metastasis on the Survival of Gefitinib Effective Patients With Non-small Cell Lung Cancer
Lead sponsor
Qilu Hospital of Shandong University
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2009
Completion date
July 12, 2015
Enrollment
265 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

overal survival, non-small cell lung cancer